Drug recall · April 19, 2017
LATANOPROST OPHTHALMIC SOLUTION recall
Why: Lack of assurance of sterility: product was found to be empty, under-filled, or leaking.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
LATANOPROST OPHTHALMIC SOLUTION, 0.005%, 125 ug/2.5 mL, packaged in 2.5 mL bottle, Rx only, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-625-12
- Lots / codes
Lot # LAB15G52, LAB11G52, Exp 6/17; LAB18I52, Exp 8/17; LAB9L52, 11/17; LAB1A62, LAB9A62, Exp 12/17
- Quantity
- 107,940 bottles
- Company
- Akorn, Inc., Lake Forest, IL
- Distribution
- Nationwide
- Initiated
- March 17, 2017 · Voluntary: Firm initiated
- Classified
- April 11, 2017
- Reported
- April 19, 2017
- Ended
- July 9, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Latanoprost
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.